Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine-Reference-Cited by-同舟云学术

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine

Published:2018-04-10 Issue:27 Volume:9 Page:19342-19355
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cabezón Marta¹²,Bargay Joan³,Xicoy Blanca¹,García Olga⁴,Borrás Josep³,Tormo Mar⁵,Marcé Sílvia¹,Pedro Carme⁶,Valcárcel David⁷,Jiménez Maria-José¹,Guàrdia Ramón⁸,Palomo Laura⁴,Brunet Salut⁹,Vall-Llovera Ferran¹⁰,Garcia Antoni¹¹,Feliu Evarist¹,Zamora Lurdes¹,

Affiliation:

1. Hematology Service, ICO Badalona-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain

2. Departament de Medicina, Universitat Autònoma de Barcelona, Badalona, Spain

3. Hematology Service, Hospital Son Llàtzer, Mallorca, Spain

4. Josep Carreras Leukemia Research Institute, Campus Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

5. Hematology Service, Hospital Clínic de Valencia, Valencia, Spain

6. Hematology Service, Hospital del Mar, Barcelona, Spain

7. Hematology Service, Hospital Vall d’Hebron, Barcelona, Spain

8. Hematology Service, ICO Girona-Hospital Josep Trueta, Girona, Spain

9. Hematology Service, Hospital de Sant Pau, Barcelona, Spain

10. Hematology Service, Hospital Mútua de Terrassa, Terrassa, Spain

11. Hematology Service, Hospital Arnau de Vilanova, Lleida, Spain

Publisher

Impact Journals, LLC